Carcinogenesis

You have full text access to this OnlineOpen article

Genetic polymorphism of the interferon-γ gene in cervical carcinogenesis

  1. Hung-Cheng Lai1,
  2. Cheng-Chang Chang1,
  3. Ya-Wen Lin2,
  4. Su-Feng Chen3,
  5. Mu-Hsien Yu1,
  6. Shin Nieh4,
  7. Ta-Wei Chu5,
  8. Tang-Yuan Chu1,2,†,*

Article first published online: 21 OCT 2004

DOI: 10.1002/ijc.20637

Issue

International Journal of Cancer

International Journal of Cancer

Volume 113, Issue 5, pages 712–718, 20 February 2005

Additional Information

How to Cite

Lai, H.-C., Chang, C.-C., Lin, Y.-W., Chen, S.-F., Yu, M.-H., Nieh, S., Chu, T.-W. and Chu, T.-Y. (2005), Genetic polymorphism of the interferon-γ gene in cervical carcinogenesis. Int. J. Cancer, 113: 712–718. doi: 10.1002/ijc.20637

Author Information

  1. 1

    Department of Obstetrics and Gynecology, Tri-Service General Hospital, Taipei, Taiwan

  2. 2

    Graduate Institutes of Medical Sciences, National Defense Medical Center, Taipei, Taiwan

  3. 3

    Institute of Clinical Dental Science, School of Dentistry, National Yang-Ming University, Taipei, Taiwan

  4. 4

    Department of Pathology, Tri-Service General Hospital, Taipei, Taiwan

  5. 5

    Department of Obstetrics and Gynecology, Army Forces Taoyuan General Hospital, Taoyuan, Taiwan

  1. †

    Fax: +886-2-8792-7199

*Department of Obstetrics and Gynecology, Tri-Service General Hospital, 325, Section 2, Cheng-Gung Road, Taipei 114, Taiwan

Publication History

  1. Issue published online: 8 DEC 2004
  2. Article first published online: 21 OCT 2004
  3. Manuscript Accepted: 6 AUG 2004
  4. Manuscript Received: 16 MAR 2004

Funded by

  • Tri-Service General Hospital, Taiwan. Grant Numbers: DOD-92-115, TSGH-C93-05-S02
  • National Science Council, Taiwan. Grant Numbers: NSC92-3112-B016-005, NSC92-3112-B016-006, NSC92-2314-B016-077
  • Taoyuan General Hospital, Taiwan. Grant Number: 804-9302
  • C.Y. Chai Foundation for Advancement of Education, Sciences and Medicine

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (244K)

References

  • 1
    Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244–65.
  • 2
    Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, Hallmans G, Dillner J. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999; 341: 1633–8.
  • 3
    Wu TC. Immunology of the human papilloma virus in relation to cancer. Curr Opin Immunol 1994; 6: 746–54.
  • 4
    Luxton JC, Rowe AJ, Cridland JC, Coletart T, Wilson P, Shepherd PS. Proliferative T cell responses to the human papillomavirus type 16 E7 protein in women with cervical dysplasia and cervical carcinoma and in healthy individuals. J Gen Virol 1996; 77(Pt 7): 1585–93.
  • 5
    Tsukui T, Hildesheim A, Schiffman MH, Lucci J III, Contois D, Lawler P, Rush BB, Lorincz AT, Corrigan A, Burk RD, Qu W, Marshall MA, et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: correlation with cervical pathology. Cancer Res 1996; 56: 3967–74.
  • 6
    Kadish AS, Ho GY, Burk RD, Wang Y, Romney SL, Ledwidge R, Angeletti RH. Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia. J Natl Cancer Inst 1997; 89: 1285–93.
  • 7
    de Gruijl TD, Bontkes HJ, van den Muysenberg AJ, van Oostveen JW, Stukart MJ, Verheijen RH, van der Vange N, Snijders PJ, Meijer CJ, Walboomers JM, Scheper RJ. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. Eur J Cancer 1999; 35: 490–7.
  • 8
    Oriss TB, McCarthy SA, Morel BF, Campana MA, Morel PA. Crossregulation between T helper cell (Th)1 and Th2: inhibition of Th2 proliferation by IFN-gamma involves interference with IL-1. J Immunol 1997; 158: 3666–72.
  • 9
    Nakamura T, Lee RK, Nam SY, Podack ER, Bottomly K, Flavell RA. Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype. J Immunol 1997; 158: 2648–53.
  • 10
    Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood 2003; 101: 2686–92.
  • 11
    Ikeda H, Old LJ, Schreiber RD. The roles of IFN gamma in protection against tumor development and cancer immunoediting. Cytokine Growth Factor Rev 2002; 13: 95–109.
  • 12
    Tartour E, Gey A, Sastre-Garau X, Lombard Surin I, Mosseri V, Fridman WH. Prognostic value of intratumoral interferon gamma messenger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst 1998; 90: 287–94.
  • 13
    Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539–45.
  • 14
    Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860–7.
  • 15
    Pohl C, Hombach A, Kruis W. Chronic inflammatory bowel disease and cancer. Hepatogastroenterology 2000; 47: 57–70.
  • 16
    Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology 2002; 16: 217–29.
  • 17
    Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, Hutchinson IV. In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 1999; 26: 1–3.
    Direct Link:
  • 18
    Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61: 863–6.
  • 19
    Gray PW, Goeddel DV. Human immune interferon (IFN-gamma) gene sequence and structure. Basic Life Sci 1983; 25: 35–61.
  • 20
    Goris A, Epplen C, Fiten P, Andersson M, Murru R, Sciacca FL, Ronsse I, Jackel S, Epplen JT, Marrosu MG, Olsson T, Grimaldi LM, et al. Analysis of an IFN-gamma gene (IFNG) polymorphism in multiple sclerosis in Europe: effect of population structure on association with disease. J Interferon Cytokine Res 1999; 19: 1037–46.
  • 21
    Jahromi M, Millward A, Demaine A. A CA repeat polymorphism of the IFN-gamma gene is associated with susceptibility to type 1 diabetes. J Interferon Cytokine Res 2000; 20: 187–90.
  • 22
    Chu TY, Hwang KS, Yu MH, Lee HS, Lai HC, Liu JY. A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites. Int J Gynecol Cancer 2002; 12: 171–6.
    Direct Link:
  • 23
    Yang YF, Tsao YP, Yin CS, Chen SL, Chu TY. Overexpression of the proto-oncogene c-jun in association with low-risk type specific human papillomavirus infection in condyloma acuminata. J Med Virol 1996; 48: 302–7.
    Direct Link:
  • 24
    Weibel ER. Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 1969; 26: 235–302.
  • 25
    Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36: 3020–7.
  • 26
    Lai HC, Sytwu HK, Sun CA, Yu MH, Yu CP, Liu HS, Chang CC, Chu TY. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 2003; 103: 221–5.
    Direct Link:
  • 27
    Dalgleish AG, O'Byrne KJ. Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv Cancer Res 2002; 84: 231–76.
  • 28
    Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R. Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 2002; 94: 1604–13.
  • 29
    Smith JS, Munoz N, Herrero R, Eluf-Neto J, Ngelangel C, Franceschi S, Bosch FX, Walboomers JM, Peeling RW. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis 2002; 185: 324–31.
  • 30
    Markowska J, Fischer N, Filas V, Fischer Z, Breborowicz J, Markowski M. The role of Chlamydia trachomatis infection in cervical cancer development. Eur J Gynaecol Oncol 1999; 20: 144–6.
  • 31
    Miyake K, Nakashima H, Akahoshi M, Inoue Y, Nagano S, Tanaka Y, Masutani K, Hirakata H, Gondo H, Otsuka T, Harada M. Genetically determined interferon-gamma production influences the histological phenotype of lupus nephritis. Rheumatology 2002; 41: 518–24.
  • 32
    Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, Oksenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun 1999; 1: 3–19.
  • 33
    Govan VA, Carrara HR, Sachs JA, Hoffman M, Stanczuk GA, Williamson AL. Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog 2003; 2: 3.
  • 34
    Vandenbroeck K, Cunningham S, Goris A, Alloza I, Heggarty S, Graham C, Bell A, Rooney M. Polymorphisms in the interferon-gamma/interleukin-26 gene region contribute to sex bias in susceptibility to rheumatoid arthritis. Arthritis Rheum 2003; 48: 2773–8.
    Direct Link:
  • 35
    Nakao F, Ihara K, Kusuhara K, Sasaki Y, Kinukawa N, Takabayashi A, Nishima S, Hara T. Association of IFN-gamma and IFN regulatory factor 1 polymorphisms with childhood atopic asthma. J Allergy Clin Immunol 2001; 107: 499–504.
  • 36
    Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, Kim CC, Kim HK, Kim TG. Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-gamma genes in the Korean population. Hum Immunol 2003; 64: 979–89.
View Full Article (HTML) Get PDF (244K)